Literature DB >> 2541923

Mutations in the cytoplasmic domain of the 275 kd mannose 6-phosphate receptor differentially alter lysosomal enzyme sorting and endocytosis.

P Lobel1, K Fujimoto, R D Ye, G Griffiths, S Kornfeld.   

Abstract

The cation-independent mannose 6-phosphate receptor (Cl-MPR) sorts newly synthesized lysosomal enzymes in the Golgi and endocytoses extracellular lysosomal enzymes. To determine the role of the 163 amino acid cytoplasmic domain of the Cl-MPR in these functions, receptor-deficient mouse L cells were transfected with normal bovine Cl-MPR cDNA or cDNAs mutated in the cytoplasmic domain. The normal Cl-MPR functioned in sorting and endocytosis. Mutant receptors with 40 and 89 residues deleted from the carboxyl terminus of the cytoplasmic tail functioned normally in endocytosis, but were partially impaired in sorting. Mutant receptors with larger deletions leaving only 7 and 20 residues of the cytoplasmic tail were defective in endocytosis and sorting. A mutant receptor containing alanine instead of tyrosine residues at positions 24 and 26 was defective in endocytosis, and partially impaired in sorting. Receptors deficient in endocytosis accumulated at the cell surface. These results indicate that the cytoplasmic domain of the Cl-MPR contains different signals for rapid endocytosis and efficient lysosomal enzyme sorting.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541923     DOI: 10.1016/0092-8674(89)90793-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  80 in total

1.  Subunit H of the V-ATPase involved in endocytosis shows homology to beta-adaptins.

Authors:  Matthias Geyer; Oliver T Fackler; B Matija Peterlin
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

Review 2.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

3.  Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains.

Authors:  A Yokota; K Yukawa; A Yamamoto; K Sugiyama; M Suemura; Y Tashiro; T Kishimoto; H Kikutani
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

4.  Clathrin-dependent association of CVAK104 with endosomes and the trans-Golgi network.

Authors:  Michael Düwel; Ernst J Ungewickell
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

Review 5.  Heterotrimeric G proteins and the single-transmembrane domain IGF-II/M6P receptor: functional interaction and relevance to cell signaling.

Authors:  C Hawkes; A Amritraj; R G Macdonald; J H Jhamandas; S Kar
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

6.  Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity.

Authors:  D A Simpson; R A Lamb
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  WNK4 enhances the degradation of NCC through a sortilin-mediated lysosomal pathway.

Authors:  Bo Zhou; Jieqiu Zhuang; Dingying Gu; Hua Wang; Liudmila Cebotaru; William B Guggino; Hui Cai
Journal:  J Am Soc Nephrol       Date:  2009-10-29       Impact factor: 10.121

Review 8.  Molecular and cellular mechanisms involved in transepithelial transport.

Authors:  E Schaerer; M R Neutra; J P Kraehenbuhl
Journal:  J Membr Biol       Date:  1991-08       Impact factor: 1.843

9.  Internalization and trafficking of guanylyl (guanylate) cyclase/natriuretic peptide receptor A is regulated by an acidic tyrosine-based cytoplasmic motif GDAY.

Authors:  Kailash N Pandey; Huong T Nguyen; Renu Garg; Madan L Khurana; Jude Fink
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

10.  The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin.

Authors:  Stephane Lefrancois; Jibin Zeng; A Jacob Hassan; Maryssa Canuel; Carlos R Morales
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.